Atlas Trials

Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer

Clinical trial NCT02358200 · TERMINATED

Trial details

NCT number
NCT02358200
Sponsor
Pamela Munster
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Triple Negative Metastatic Breast CancerBRCA-mutated Solid Tumor
Start date
2015-02-23
Primary completion
2019-01-08
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.